Key result
Suxiao jiuxin wan compared with nitroglycerin improved ECG measurements (RR 1.16; 95% CI 1.05-1.27) and reduced symptoms (RR 1.09; 95% CI 1.04-1.13) in patients with angina pectoris.
Why the study?
Does suxiao jiuxin wan improve symptoms and ECG measurements in patients with angina pectoris?
Systematic Review (n=1,776)
Does suxiao jiuxin wan improve symptoms and ECG measurements in patients with angina pectoris?
Relative Risk: 1.16 (95% CI 1.05–1.27)
Suxiao jiuxin wan appears to be effective for angina pectoris, but the evidence is weak due to poor methodological quality of the included trials.
No takes yet. Share an insight, caveat, or question.
May support suxiao jiuxin wan for angina symptoms; leaves open efficacy pending higher-quality trials.
Duan et al. (2008) conducted a systematic review in Angina pectoris (n=1,776). Suxiao jiuxin wan vs. Standard treatment (e.g., nitroglycerin, Salvia miltiorrhiza, isosorbide dinitrate) was evaluated on ECG measurements (vs nitroglycerin) (RR 1.16, 95% CI 1.05 to 1.27). Suxiao jiuxin wan compared with nitroglycerin improved ECG measurements (RR 1.16; 95% CI 1.05-1.27) and reduced symptoms (RR 1.09; 95% CI 1.04-1.13) in patients with angina pectoris.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: